Patient Guide: A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 24 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06746116
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced or Recurrent Endometrial Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 24 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • A Coruña,
  • Alicante,
  • Barakaldo,
  • • And 21 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily